Key Events This Week
22 Jun: Stock opens at Rs.158.65, marginal decline of 0.09%
23 Jun: Intraday high of Rs.173.90 with 8.73% surge and record volume
24 Jun: Continued robust trading with 1.32 crore shares and 1.78% gain
25 Jun: Price retreats to Rs.167.65, down 2.81%
26 Jun: Week closes at Rs.167.65, net weekly gain of 5.57%
22 June 2026: Modest Start Amid Positive Sensex Momentum
Piramal Pharma Ltd began the week at Rs.158.65, a slight decline of 0.09% from the previous close. Trading volume was relatively low at 1,13,636 shares. Meanwhile, the Sensex closed higher by 0.46% at 36,342.26, reflecting broader market optimism. The stock’s subdued start contrasted with the market’s positive tone, setting the stage for a volatile week ahead.
23 June 2026: Intraday Surge and Exceptional Volume Signal Reversal
The stock witnessed a remarkable turnaround on 23 June, surging 6.33% to close at Rs.168.70. Intraday, it touched a high of Rs.173.90, marking an 8.73% increase from the previous day’s close. This rally followed five consecutive sessions of decline, signalling a potential trend reversal. Trading volume exploded to 4,142,386 shares, with a traded value of approximately ₹289.46 crores, making Piramal Pharma one of the most actively traded stocks by value and volume on the day.
Institutional interest was evident, with delivery volumes on 22 June rising by 107.79% compared to the five-day average, indicating strong accumulation. The stock outperformed its sector by nearly 7% and the Sensex by over 7.5%, which declined 1.05% that day. Technically, the price moved above its 5-day, 20-day, 50-day, and 100-day moving averages, though it remained below the 200-day average, suggesting short-term bullish momentum amid longer-term resistance.
Just announced: This Small Cap from Tyres & Allied with precise target price is our pick for the week. Get the pre-market insights that informed this selection!
- - Just announced pick
- - Pre-market insights shared
- - Tyres & Allied weekly focus
24 June 2026: Sustained Momentum with Robust Institutional Participation
Building on the previous day’s gains, Piramal Pharma Ltd continued its upward trajectory on 24 June, closing at Rs.172.50, a 2.25% increase. The stock recorded a traded volume of 1.31 crore shares and a traded value of ₹228.92 crores, maintaining its position among the highest value traded stocks. Delivery volume surged by 305.85% compared to the five-day average, underscoring strong institutional buying interest.
The stock outperformed the Pharmaceuticals & Biotechnology sector, which gained 0.33%, and the Sensex, which rose 0.53%. Price action remained above key moving averages except the 200-day, signalling continued short- to medium-term bullish momentum. Despite this, the Mojo Score remained at 40.0 with a Sell grade, reflecting caution on fundamentals and valuation.
25 June 2026: Profit Taking Leads to Price Correction
On 25 June, the stock retreated by 2.81% to close at Rs.167.65 on lower volume of 4,29,191 shares. This pullback followed two days of strong gains and may represent profit-taking by traders. The Sensex also declined marginally by 0.05%, closing at 36,133.32. The stock’s price remained above short-term moving averages but below the 200-day average, maintaining a mixed technical outlook.
Why settle for Piramal Pharma Ltd? SwitchER evaluates this small-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- - Comprehensive evaluation done
- - Superior opportunities identified
- - Smart switching enabled
Daily Price Comparison: Piramal Pharma Ltd vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-06-22 | Rs.158.65 | -0.09% | 36,342.26 | +0.46% |
| 2026-06-23 | Rs.168.70 | +6.33% | 35,959.97 | -1.05% |
| 2026-06-24 | Rs.172.50 | +2.25% | 36,151.68 | +0.53% |
| 2026-06-25 | Rs.167.65 | -2.81% | 36,133.32 | -0.05% |
Key Takeaways from the Week
Positive Signals: The stock’s 5.57% weekly gain notably outperformed the Sensex’s 0.11% decline, driven by strong institutional interest and exceptional volume surges on 23 and 24 June. Delivery volumes increased dramatically, signalling accumulation rather than short-term trading. The price consistently traded above short- and medium-term moving averages, indicating bullish momentum in the near term.
Cautionary Signals: Despite the price recovery, the stock remains below its 200-day moving average, a key resistance level for confirming a sustained uptrend. The Mojo Score of 40.0 and a Sell grade, downgraded in April 2026, reflect underlying concerns about fundamentals and valuation. The price correction on 25 June suggests profit-taking and potential volatility ahead.
Overall, the week’s trading activity highlights a tentative shift in market sentiment towards Piramal Pharma Ltd, with strong volume and price action tempered by cautious technical and fundamental indicators.
Conclusion
Piramal Pharma Ltd’s performance during the week ending 26 June 2026 was marked by a significant rebound from prior declines, driven by exceptional trading volumes and institutional buying interest. The stock’s 5.57% weekly gain contrasted with the Sensex’s slight fall, underscoring its relative strength within the Pharmaceuticals & Biotechnology sector. However, the persistent technical resistance at the 200-day moving average and the Sell rating from MarketsMOJO advise prudence.
Investors and market participants should monitor upcoming sessions for confirmation of sustained momentum or signs of reversal. The interplay between short-term bullish signals and longer-term caution will likely define the stock’s trajectory in the near future.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
